Target intelligence / Profile preview

Wiskott-Aldrich syndrome protein family member 1 (WASF1)

Target
WASF1
Molecular classification
Actin-binding protein, Signal transduction adaptor, Other (WASP family protein, WAVE complex component)
01

Overview

Wiskott-Aldrich syndrome protein family member 1 (WASF1), also known as WAVE1, is an actin-binding protein and key effector in the WAVE regulatory complex, mediating signals from tyrosine kinase receptors and Rho-family GTPases to the actin cytoskeleton[1][2][5]. WASF1 is essential for actin filament nucleation and reorganization through interactions with the Arp2/3 complex, crucial for cellular processes such as membrane ruffling, lamellipodia formation, and cell movement. It further participates in endocytic trafficking, mitochondrial dynamics, and cellular pathways influencing cell survival and chemoresistance. Loss-of-function mutations in WASF1 are associated with neurodevelopmental disorders characterized by intellectual disability, language impairment, and seizures[2][3].

Other names
WASP-family verprolin homologous protein 1WAVE1SCAR1KIAA0269NEDALVSProtein WAVE-1Verprolin homology domain-containing protein 1
02

Biological functions

Regulation of actin cytoskeletonSignal transduction from tyrosine kinase receptors and small GTPasesRegulates lamellipodia formationPromotes actin filament formationInvolved in BDNF-NTRK2 trafficking and mitochondrial dynamics
03

Disease associations

Neurodevelopmental disorder (with absent language and variable seizures)Intellectual disabilityImmune dysregulation (Wiskott-Aldrich syndrome context)Cancer (notably implicated in chemoresistance in leukemia)

Beyond the preview

Go deeper on Wiskott-Aldrich syndrome protein family member 1 (WASF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wiskott-Aldrich syndrome protein family member 1 (WASF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call